Progenics Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch PGNX and buy or sell other stocks, options, and ETFs commission-free!

About PGNX

Progenics Pharmaceuticals, Inc., of Tarrytown, N.Y., is a biopharmaceutical company focused on innovative therapeutics for patients suffering from cancer and related conditions. Progenics' pipeline candidates include PSMA ADC, a human monoclonal antibody-drug conjugate in phase 2 testing for treatment of prostate cancer, and preclinical stage novel multiplex phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of cancer.

CEO

David W. Mims, CPA

CEODavid W. Mims, CPA

Employees

—

Employees—

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

1986

Founded1986

Employees

—

Employees—

PGNX Key Statistics

Market cap

355.05M

Market cap355.05M

Price-Earnings ratio

-5.30

Price-Earnings ratio-5.30

Dividend yield

—

Dividend yield—

Average volume

4.50M

Average volume4.50M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.37

52 Week high$6.37

52 Week low

$1.89

52 Week low$1.89